Figen Abatay-Sel

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 14, 2025
Do the expressions of HLA-G and killer cell immunoglobulin-like receptors change in colorectal cancer?

Ezgi Dinçer, Fatma Kaya Dağistanli, Kıvanç Derya Peker

|Jul 17, 2024
The Cytokine Levels of Cord Blood- and Wharton's Jelly-Derived Mesenchymal Stem Cells from Early to Late Passages.

Ayşe Erol Bozkurt, Figen Abatay Sel, Mediha Suleymanoğlu

|Mar 20, 2023
Evaluation of the relationship between mesenchymal stem cells and immune system in vitro conditions.

Ayşe Erol, Figen Abatay Sel, Mediha Süleymanoğlu

|Feb 22, 2023
The in vitro treatment of mesenchymal stem cells for colorectal cancer cells.

Figen Abatay-Sel, Ayse Erol, Mediha Suleymanoglu

|Feb 16, 2023
Increasing Apoptotic Effect of Cord Blood and Wharton's Jelly-derived Mesenchymal Stem Cells on HT-29.

Figen Abatay-Sel, Ayse Erol, Mediha Suleymanoglu

Pageof 1